Since 2014, a strong and enduring partnership has been established between the Tropical Disease Foundation (TDF) and TB Alliance (The Global Alliance for TB Drug Development). This collaboration has spanned a broad range of initiatives, beginning with joint efforts in clinical trials and researching new tuberculosis (TB) medicines, and extending to meaningful community engagement activities aimed at strengthening the TB response at multiple levels. Over the years, the partnership has further evolved through participation in key programs such as LIFT-TB (Leveraging Innovation for Faster Treatment of Tuberculosis) and PeerLINC (Peer-to-Peer Learning for Innovative Cures). Together, these initiatives have contributed to advancing innovative approaches, strengthening knowledge exchange, and accelerating progress toward more effective TB treatment and control.
